January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular ...
January 22, 2024 — The American College of Cardiology is again urging members of Congress to retroactively eliminate the ...
January 22, 2024 — A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
January 22, 2024 — Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently ...
January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk ...
January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
January 19, 2024 — Heart rhythm expert Sumeet Chugh, MD, associate director of the Smidt Heart Institute at Cedars-Sinai ...
January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed ...
January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
January 18, 2024 — A new American Heart Association (AHA) policy statement examines the history of structural racism ...
January 17, 2024 — One of the Smidt Heart Institute’s leading experts in artificial intelligence, David Ouyang, MD, has ...
January 17, 2024 — This review was jointly published by Prof. Long-Jiang Zhang (Department of Radiology, Jinling ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
January 16, 2024 — Cardiac Dimensions, a leader in the development of innovative and minimally invasive treatment ...
January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same ...
January 16, 2024 — Penumbra, Inc., a thrombectomy company, has recently secured CE Mark (Conformité Européenne) for its ...
January 22, 2024
